Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PYPD compared with APRE: revenue, margins and what each company keeps, and the suppliers and customers both name
PYPD
PolyPid Ltd.
Change
Mkt cap
Revenue
Revenue
APRE
Aprea Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PYPD
PolyPid Ltd.
vs
APRE
Aprea Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
PYPD
PolyPid Ltd.
Change
5.35
▼
−1.29%
· post 5.50
Mkt cap
$88.6M
Revenue
—
Revenue
—
APRE
Aprea Therapeutics, Inc.
Change
0.50
▲
+1.96%
· post 0.50
Closed
Nov 3 '26
Mkt cap
$6.1M
Revenue
$3,337
Q4 FY25
Revenue
$285,759
FY25
vs
Compare
Closed
Nov 3 '26
PYPD
PolyPid Ltd.
vs
APRE
Aprea Therapeutics, Inc.
5.35
▼
−1.29%
post 5.50
Price
0.50
▲
+1.96%
post 0.50
$88.6M
Mkt cap
$6.1M
—
Revenue
$3,337
Q4 FY25
—
Revenue
$285,759
FY25
Change
Change
PYPD
5.35
▼
−1.29%
vs
APRE
0.50
▲
+1.96%
Closed
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
PYPD: latest quarter not drawable. APRE: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: PYPD, APRE.
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PYPD, solid
APRE, dashed